Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV
Clinical trial NCT05551273 · COMPLETED
Trial details
- NCT number
- NCT05551273
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-05
- Primary completion
- 2025-10-29
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.